Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Seres Therapeutics (MCRB) Change in Inventory: 2023-2024

Historic Change in Inventory for Seres Therapeutics (MCRB) over the last 2 years, with Sep 2024 value amounting to $10.4 million.

  • Seres Therapeutics' Change in Inventory fell 20.78% to $10.4 million in Q3 2024 from the same period last year, while for Sep 2024 it was $44.9 million, marking a year-over-year change of. This contributed to the annual value of $33.8 million for FY2024, which is 13.99% up from last year.
  • Latest data reveals that Seres Therapeutics reported Change in Inventory of $10.4 million as of Q3 2024, which was down 5.25% from $11.0 million recorded in Q2 2024.
  • Over the past 5 years, Seres Therapeutics' Change in Inventory peaked at $13.2 million during Q3 2023, and registered a low of $5.3 million during Q2 2023.
  • Its 2-year average for Change in Inventory is $10.6 million, with a median of $11.1 million in 2023.
  • Data for Seres Therapeutics' Change in Inventory shows a peak YoY increase of 106.44% (in 2024) and a maximum YoY decrease of 20.78% (in 2024) over the last 5 years.
  • Seres Therapeutics' Change in Inventory (Quarterly) stood at $11.1 million in 2023, then dropped by 20.78% to $10.4 million in 2024.
  • Its Change in Inventory stands at $10.4 million for Q3 2024, versus $11.0 million for Q2 2024 and $12.3 million for Q1 2024.